Quantifying preferences for watch-and-wait compared with surgery after a clinical complete response in locally advanced rectal cancer: A discrete choice experiment (PrefCoRe)

Cancer Research UK. Distribution of cases by anatomic site 〈https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/incidence#heading-Three〉 [accessed 07 November 2023].

[2]

Renehan "Techniques and outcome of surgery for locally advanced and local recurrent rectal cancer" Clin Oncol (R Coll Radio) (2016) 10.1016/j.clon.2015.11.006

[3]

Colorectal cancer

Cathy Eng, Takayuki Yoshino, Erika Ruíz-García et al.

The Lancet 2024 10.1016/s0140-6736(24)00360-x

[4]

Renehan "Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis" Lancet Oncol (2016) 10.1016/s1470-2045(15)00467-2

[5]

Downing "Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England" Int J Radiat Oncol Biol Phys (2019) 10.1016/j.ijrobp.2018.12.005

[6]

Vonk-Klaassen "Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review" Qual Life Res (2016) 10.1007/s11136-015-1050-3

[7]

Glynne-Jones "Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation" Br J Surg (2012) 10.1002/bjs.8732

[8]

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Alessandro Audisio, Chiara Gallio, Vaneja Velenik et al.

JAMA Oncology 2025 10.1001/jamaoncol.2025.2026

[9]

Fokas "International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer" Nat Rev Clin Oncol (2021) 10.1038/s41571-021-00538-5

[10]

Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer

Monique Maas, Regina G.H. Beets-Tan, Doenja M.J. Lambregts et al.

Journal of Clinical Oncology 2011 10.1200/jco.2011.37.7176

[11]

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

Maxime J M van der Valk, Denise E Hilling, Esther Bastiaannet et al.

The Lancet 2018 10.1016/s0140-6736(18)31078-x

[12]

Fernandez "The risk of distant metastases in patients with clinical complete response managed by watch and wait after neoadjuvant therapy for rectal cancer: the influence of local regrowth in the international watch and wait database" Dis Colon Rectum (2023) 10.1097/dcr.0000000000002494

[13]

Hermus "Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO-study" Int J Cancer (2023) 10.1002/ijc.34327

[14]

Colorectal Pathway Board. Greater Manchester Pathway Board Colorectal Cancer Surveillance Guidelines 2019 2019.

[15]

Custers "Long-term quality of life and functional outcome of patients with rectal cancer following a watch-and-wait approach" JAMA Surg (2023) 10.1001/jamasurg.2023.0146

[16]

Gilbert Lancet Healthy Longev (2022) 10.1016/s2666-7568(22)00239-2

[17]

Hupkens "Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study" Dis Colon Rectum (2017) 10.1097/dcr.0000000000000862

[18]

Breugom "Is it time for watchful waiting for rectal cancer?" Lancet Oncol (2015) 10.1016/s1470-2045(15)00015-7

[19]

Perez "Complete clinical response in rectal cancer: a turning tide" Lancet Oncol (2016) 10.1016/s1470-2045(15)00487-8

[20]

Gunjur "Pilot study of patients' preferences for immediate resection versus a watch and wait approach after neoadjuvant chemoradiation for locally advanced rectal cancer" JCO Oncol Pr (2021) 10.1200/op.20.00158

[21]

van der Valk "Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?" Eur J Surg Oncol (2020) 10.1016/j.ejso.2020.04.014

[22]

Gani "Organ preservation in rectal cancer: the patients' perspective" Front Oncol (2019) 10.3389/fonc.2019.00318

[23]

Noordman "Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer" Br J Surg (2018) 10.1002/bjs.10897

[24]

van der Wilk "Preferences for active surveillance or standard oesophagectomy: discrete-choice experiment" Br J Surg (2022) 10.1093/bjs/znab358

[25]

Discrete Choice Experiments in Health Economics: Past, Present and Future

Vikas Soekhai, Esther W. de Bekker-Grob, Alan R. Ellis et al.

PharmacoEconomics 2019 10.1007/s40273-018-0734-2

[26]

de Bekker-Grob "Discrete choice experiments in health economics: a review of the literature" Health Econ (2012) 10.1002/hec.1697

[27]

Hall "Attributes used for cancer screening discrete choice experiments: a systematic review" Patient PatientCent Outcomes Res (2022) 10.1007/s40271-021-00559-3

[28]

Collacott "A systematic review of discrete choice experiments in oncology treatments" Patient PatientCent Outcomes Res (2021) 10.1007/s40271-021-00520-4

[29]

de Bekker-Grob "Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment" Br J Cancer (2013) 10.1038/bjc.2013.370

[30]

de Bekker-Grob "Patients' preferences for surgical management of esophageal cancer: a discrete choice experiment" World J Surg (2015) 10.1007/s00268-015-3148-8

[31]

Wright "How do women want to receive information about non-invasive prenatal testing? Evidence from a discrete choice experiment" Prenat Diagn (2022) 10.1002/pd.6243

[32]

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

John F.P. Bridges, A. Brett Hauber, Deborah Marshall et al.

Value in Health 2011 10.1016/j.jval.2010.11.013

[33]

Lancsar "Discrete choice experiments: a guide to model specification, estimation and software" Pharmacoeconomics (2017) 10.1007/s40273-017-0506-4

[34]

Ride "A reporting checklist for discrete choice experiments in health: the DIRECT checklist" PharmacoEconomics (2024) 10.1007/s40273-024-01431-6

[35]

Sawtooth Software. Lighthouse Studio. 9.10.0. Orem, Utah 2021.

[36]

Keulemans "Laparoscopic cholecystectomy: day-care versus clinical observation" Ann Surg (1998) 10.1097/00000658-199812000-00003

[37]

Nieuwkerk "Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate" Fertil Steril (1998) 10.1016/s0015-0282(98)00213-1

[38]

Vass "A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies" Patient (2020) 10.1007/s40271-019-00391-w

[39]

SciAni. Sci Ani: Science Animated. 2024.

[40]

ChoiceMetrics. Ngene User Manual 1.1.1. ChoiceMetrics; 2012.

[41]

StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015.

[42]

Seghers "Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review" Cancers (Basel) (2022) 10.3390/cancers14051147

[43]

National Bowel Cancer Audit State of the Nation Report. An audit of care received by people diagnosed or undergoing surgery for bowel cancer between 1 January 2023 and 31 December 2023 in England and Wales. https://www.natcan.org.uk/reports/nboca-state-of-the-nation-report-2025/ [accessed 9 January 2026]. 2025.

[44]

Thrumurthy "Discrete-choice preference comparison between patients and doctors for the surgical management of oesophagogastric cancer" Br J Surg (2011) 10.1002/bjs.7537

Metrics

0

Citations

44

References

Details

Published: May 01, 2026
Vol/Issue: 238
Pages: 116589
License: View

Authors

Department of Health Systems and Population Health; School of Public Health, University of Washington; Seattle WA USA

Funding

Wellcome Trust Award: 226922/Z/23/Z

NIHR Imperial Biomedical Research Centre Award: NIHR203308

Manchester Biomedical Research Centre

Cite This Article

Garima Dalal, Stuart J. Wright, Lee Malcomson, et al. (2026). Quantifying preferences for watch-and-wait compared with surgery after a clinical complete response in locally advanced rectal cancer: A discrete choice experiment (PrefCoRe). European Journal of Cancer, 238, 116589. https://doi.org/10.1016/j.ejca.2026.116589

Quantifying preferences for watch-and-wait compared with surgery after a clinical complete response in locally advanced rectal cancer: A discrete choice experiment (PrefCoRe)

You May Also Like